Global WholeHealth Partners Corporation (GWHP)
USD 0.0
(-90.0%)
USD 0.0
(-90.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | - USD | 100.0% |
| 2022 | -6.12 Million USD | -10.94% |
| 2021 | -5.52 Million USD | -28.22% |
| 2020 | -4.3 Million USD | -15419.64% |
| 2019 | -27.74 Thousand USD | -2211.83% |
| 2018 | -1200.00 USD | -458.14% |
| 2017 | -215.00 USD | 0.0% |
| 2014 | -99.26 Thousand USD | 7.06% |
| 2013 | -106.8 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2023 FY | - USD | 100.0% |
| 2023 Q4 | - USD | 0.0% |
| 2023 Q2 | - USD | 0.0% |
| 2023 Q1 | - USD | 100.0% |
| 2022 Q2 | -2.61 Million USD | -82.65% |
| 2022 Q1 | -1.43 Million USD | -124.05% |
| 2022 FY | -6.12 Million USD | -10.94% |
| 2022 Q4 | -172.05 Thousand USD | 81.59% |
| 2022 Q3 | -934.7 Thousand USD | 64.29% |
| 2021 FY | -5.52 Million USD | -28.22% |
| 2021 Q3 | -7.96 Million USD | -4188.42% |
| 2021 Q4 | -639.68 Thousand USD | 91.97% |
| 2021 Q2 | -185.65 Thousand USD | 24.89% |
| 2021 Q1 | -247.16 Thousand USD | 94.12% |
| 2020 FY | -4.3 Million USD | -15419.64% |
| 2020 Q4 | -4.2 Million USD | -36051.02% |
| 2020 Q2 | -51.09 Thousand USD | -171.83% |
| 2020 Q1 | -18.79 Thousand USD | 11.58% |
| 2020 Q3 | -11.62 Thousand USD | 77.24% |
| 2019 Q4 | -21.25 Thousand USD | -136.0% |
| 2019 FY | -27.74 Thousand USD | -2211.83% |
| 2019 Q2 | -300.00 USD | 75.0% |
| 2019 Q1 | -1200.00 USD | 0.0% |
| 2019 Q3 | -9008.00 USD | -2902.67% |
| 2018 FY | -1200.00 USD | -458.14% |
| 2017 FY | -215.00 USD | 0.0% |
| 2015 Q3 | -1770.00 USD | 96.42% |
| 2015 Q1 | -125.01 Thousand USD | -116.75% |
| 2015 Q2 | -49.38 Thousand USD | 60.5% |
| 2014 Q1 | -31.55 Thousand USD | 11.37% |
| 2014 Q4 | -57.67 Thousand USD | -731.31% |
| 2014 Q3 | -6938.00 USD | -124.31% |
| 2014 Q2 | -3093.00 USD | 90.2% |
| 2014 FY | -99.26 Thousand USD | 7.06% |
| 2013 Q4 | -35.6 Thousand USD | -395477.78% |
| 2013 FY | -106.8 Thousand USD | 0.0% |
| 2013 Q3 | -9.00 USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.41 Million USD | 100.0% |
| Arrayit Corporation | -3.31 Million USD | 100.0% |
| Atlantic International Corp. | -5.62 Million USD | 100.0% |
| Biocept, Inc. | -32.08 Million USD | 100.0% |
| Bioqual, Inc. | 483.48 Thousand USD | 100.0% |
| CardioGenics Holdings Inc | -1.91 Million USD | 100.0% |
| DermTech, Inc. | -100.88 Million USD | 100.0% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.02 Billion USD | 100.0% |
| HTG Molecular Diagnostics, Inc. | -21.59 Million USD | 100.0% |
| iMD Companies, Inc. | -200.63 Thousand USD | 100.0% |
| IDenta Corp. | 14.64 Thousand USD | 100.0% |
| Interpace Biosciences, Inc. | 802 Thousand USD | 100.0% |
| Integrative Health Technologies, Inc. | 38.68 Thousand USD | 100.0% |
| InVitro International | 1553.00 USD | 100.0% |
| Lumos Diagnostics Holdings Limited | -8.59 Million USD | 100.0% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | 100.0% |
| Medical Imaging Corp. | -3.02 Million USD | 100.0% |
| NovelStem International Corp. | -4.18 Million USD | 100.0% |
| Optigenex Inc. | -2.89 Million USD | 100.0% |
| PharmChem, Inc. | 845.1 Thousand USD | 100.0% |
| Proteome Sciences plc | -2.44 Million USD | 100.0% |
| Response Genetics, Inc | -20.18 Million USD | 100.0% |
| Rennova Health, Inc. | -3.29 Million USD | 100.0% |
| RushNet, Inc. | -607.02 Thousand USD | 100.0% |
| ScreenPro Security Inc. | -2.24 Million USD | 100.0% |
| Stella Diagnostics Inc. | -5.7 Million USD | 100.0% |
| StageZero Life Sciences Ltd. | -11.41 Million USD | 100.0% |
| Todos Medical Ltd. | -24.99 Million USD | 100.0% |